Evaluation of Bis-Benzimidazoles in the Treatment of Murine Lymphocytic Choriomeningitis Virus Infections
Explore this paper's citation graph
Summary
Drug treatment during the first 7 days after infection was found to have no significant effect on virus titers in various organs, and the sparing effect of the drug is discussed in terms of immunosuppression.
- Type
- article
- Published
- 1974-12-01
- Cited by
- 4
- References
- 7
- Access
- Open access
- OpenAlex
- https://openalex.org/W2031121641
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:11242566
Keywords
Lymphocytic choriomeningitis, Immunosuppression, Virus, Virology, Titer
References
- STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 4. THE QUESTION OF IMMUNITY IN ADOPTIVELY IMMUNIZED VIRUS CARRIERS.
- Antiviral Activity of a bis-Benzimidazole Against Experimental Rhinovirus Infections in Chimpanzees
- Plaque size heterogeneity: a genetic trait of lymphocytic choriomeningitis virus.
- Characteristics of the In Vitro Inhibition of Arenavirus Synthesis by Bis-Benzimidazoles
- SPECTRUM AND CHARACTERISTICS OF THE VIRUS INHIBITORY ACTION OF 2-(α-HYDROXYBENZYL)-BENZIMIDAZOLE
- Persistent and Slow Virus Infections
- Antiviral Activity of a bis-Benzimidazole Against Experimental Rhinovirus Infections in Chimpanzees1
Cited by
Related papers
- Differential Inhibition of Macrophage Activation by Lymphocytic Choriomeningitis Virus and Pichinde Virus Is Mediated by the Z Protein N-Terminal Domain
- Novel Arenavirus Infection in Humans, United States
- Visualizing lymphocytic choriomeningitis virus infection in cells and living mice
- Inhibition of the Type I Interferon Response by the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus
- Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
- The C-Terminal Region of Lymphocytic Choriomeningitis Virus Nucleoprotein Contains Distinct and Segregable Functional Domains Involved in NP-Z Interaction and Counteraction of the Type I Interferon Response
- Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein